CyberKnife to be focus of numerous presentations at the American Society for Radiation Oncology (ASTRO) annual meeting
Author: press release
Accuray Incorporated, a global leader in the field of radiosurgery, announced today
that 28 CyberKnife-focused abstracts have been accepted as part of the 51st
Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking
place November 1 – 5 in Chicago, Illinois. This represents a 27 percent
increase in CyberKnife abstracts over last year’s Annual Meeting.
The accepted abstracts, which will be presented as posters or oral
presentations, focus on the use of the CyberKnife® Robotic Radiosurgery System
to treat tumors located throughout the body including the prostate, lung,
brain, spine, liver, pancreas, head and neck.
“The depth and breadth of research presented at this year’s ASTRO meeting is a
testament to the growing clinical acceptance of the CyberKnife System and the
important role it is playing in the treatment of cancer,” said Euan Thomson,
Ph.D., president and CEO of Accuray.
Highlights of the research that will be showcased include seven presentations
focusing on the use of CyberKnife radiosurgery to treat prostate cancer.
CyberKnife prostate procedures from July-September 2009 increased 21 percent
over the same period the previous year, confirming the increasing demand for
this treatment option. To date, CyberKnife radiosurgery has been used to treat
more than 4,000 men with prostate cancer.
Additionally, Accuray will host a number of presentations in the company’s
booth reporting on experience with CyberKnife radiosurgery. Presenters
include Eric Lartigau, M.D., Ph.D., from Centre Oscar Lambret; Xiaodong Wu,
Ph.D., from University of Miami; Donald B. Fuller, M.D., from CyberKnife
Centers of San Diego; Brian T. Collins, M.D., from Georgetown University
Hospital; Joe Y. Chang, M.D., Ph.D., from M. D. Anderson Cancer Center; Debra
Freeman, M.D., from Naples Radiation Oncology; Sonja Dieterich, Ph.D., and
Iris Gibbs, M.D., from Stanford University Hospital; Kim Huang, M.D., from
University of California San Francisco; and Greg Spurlock from US
About the CyberKnife® Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world’s only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization